Daniel Bradbury

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
La Jolla, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Anthony Baldor, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel Bradbury

Form 4 holding Director

Vivani Medical, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
36,516
Estimated value
$58,070
Report date
24 Jun 2026
Price
$1.23
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CASTLE BIOSCIENCES INC

Security class
Restricted Stock Units
Shares / value
11,766
Estimated value
$0
Report date
28 May 2026
Price
$24.95
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHAIRMAN, Director

Equillium, Inc.

Security class
Director stock option (right to buy)
Shares / value
70,000
Estimated value
Report date
28 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHAIRMAN, Director

Equillium, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
14 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel Bradbury

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .